Pharmaust finds buyer for CBI

By Dylan Bushell-Embling
Tuesday, 10 June, 2008

WA generic medicines company Pharmaust (ASX: PAA) has found a buyer for its share in Commonwealth Biotechnologies Inc (CBI), a US-based life sciences R&D outsourcing specialist.

In a statement, Pharmaust's board said it had decided that ownership of the shares was doing nothing to help the company's bottom line, but had run into difficulties selling the shares.

The shares were unregistered, meaning they could not be sold on the NASDAQ exchange and had to be sold privately.

The company has finally sourced a likely buyer, Hong Kong-based Venturepharm Laboratories.

Pharmaust shareholders will be asked to vote on the deal on July 11.

Related News

Does exercise really extend lifespan? It's complicated

Physical activity is seen as a way to extend the human lifespan, but the benefits of physical...

Nature helps to relieve physical pain

Experiencing nature, even in the form of watching nature videos, can alleviate acute physical pain.

SEQ koala population carries immunity to retrovirus

Koalas from a population north of the Brisbane River appear to have evolved a unique genomic...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd